GFRA1 and lung carcinoma: Although Salamat et al. described GFRA1 as one of the genes differentially methylated between cancerous and non-cancerous tissue obtained from lung cancer patients subclustered on the basis of DNA methylation profiles [16], the clinicopathological impact of DNA methylation of the GFRA1 gene was not examined in LADCs.